Chlorine in PDB 4jrg: The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor
Protein crystallography data
The structure of The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor, PDB code: 4jrg
was solved by
B.J.Graves,
C.A.Janson,
C.Lukacs,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
28.03 /
1.90
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
73.542,
72.796,
43.865,
90.00,
111.78,
90.00
|
R / Rfree (%)
|
29.7 /
32.8
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor
(pdb code 4jrg). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor, PDB code: 4jrg:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 4jrg
Go back to
Chlorine Binding Sites List in 4jrg
Chlorine binding site 1 out
of 4 in the The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl201
b:31.9
occ:1.00
|
CL2
|
A:I09201
|
0.0
|
31.9
|
1.0
|
C23
|
A:I09201
|
1.8
|
32.2
|
1.0
|
C22
|
A:I09201
|
2.7
|
30.9
|
1.0
|
C24
|
A:I09201
|
2.7
|
30.0
|
1.0
|
CG
|
A:HIS92
|
3.6
|
28.8
|
1.0
|
CA
|
A:HIS92
|
3.6
|
30.8
|
1.0
|
CE2
|
A:TYR96
|
3.7
|
31.0
|
1.0
|
CB
|
A:HIS92
|
3.7
|
29.6
|
1.0
|
CD2
|
A:LEU50
|
3.7
|
24.6
|
1.0
|
CG2
|
A:ILE95
|
3.7
|
24.3
|
1.0
|
CD2
|
A:TYR96
|
3.7
|
28.6
|
1.0
|
O
|
A:HIS92
|
3.7
|
30.6
|
1.0
|
CB
|
A:ILE95
|
3.8
|
28.0
|
1.0
|
CD2
|
A:HIS92
|
3.8
|
29.5
|
1.0
|
C21
|
A:I09201
|
4.0
|
30.7
|
1.0
|
C25
|
A:I09201
|
4.0
|
31.3
|
1.0
|
CD1
|
A:LEU50
|
4.1
|
30.4
|
1.0
|
ND1
|
A:HIS92
|
4.1
|
29.1
|
1.0
|
C
|
A:HIS92
|
4.2
|
31.6
|
1.0
|
CD1
|
A:ILE95
|
4.2
|
29.2
|
1.0
|
NE2
|
A:HIS92
|
4.4
|
29.3
|
1.0
|
CG
|
A:LEU50
|
4.5
|
30.2
|
1.0
|
C26
|
A:I09201
|
4.5
|
29.3
|
1.0
|
CE1
|
A:HIS92
|
4.6
|
28.8
|
1.0
|
CG1
|
A:ILE95
|
4.6
|
27.4
|
1.0
|
N
|
A:TYR96
|
4.7
|
28.6
|
1.0
|
N
|
A:HIS92
|
4.8
|
31.9
|
1.0
|
CZ
|
A:TYR96
|
5.0
|
33.3
|
1.0
|
CA
|
A:ILE95
|
5.0
|
26.6
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 4jrg
Go back to
Chlorine Binding Sites List in 4jrg
Chlorine binding site 2 out
of 4 in the The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl201
b:42.5
occ:1.00
|
CL3
|
A:I09201
|
0.0
|
42.5
|
1.0
|
C34
|
A:I09201
|
1.8
|
35.4
|
1.0
|
C35
|
A:I09201
|
2.7
|
35.6
|
1.0
|
C33
|
A:I09201
|
2.7
|
34.6
|
1.0
|
CE2
|
A:PHE82
|
3.7
|
31.6
|
1.0
|
CD1
|
A:ILE57
|
3.8
|
30.8
|
1.0
|
CZ
|
A:PHE87
|
3.8
|
30.4
|
1.0
|
CZ
|
A:PHE82
|
3.9
|
28.5
|
1.0
|
CG2
|
A:ILE95
|
4.0
|
24.3
|
1.0
|
C36
|
A:I09201
|
4.0
|
33.8
|
1.0
|
CE1
|
A:PHE87
|
4.0
|
31.6
|
1.0
|
C32
|
A:I09201
|
4.0
|
33.8
|
1.0
|
CB
|
A:LEU53
|
4.1
|
27.3
|
1.0
|
CD1
|
A:LEU53
|
4.1
|
27.4
|
1.0
|
C31
|
A:I09201
|
4.6
|
34.7
|
1.0
|
CG
|
A:LEU53
|
4.7
|
28.6
|
1.0
|
CG1
|
A:ILE95
|
4.9
|
27.4
|
1.0
|
CD2
|
A:PHE82
|
4.9
|
31.5
|
1.0
|
CD1
|
A:ILE95
|
4.9
|
29.2
|
1.0
|
CG1
|
A:ILE57
|
5.0
|
32.7
|
1.0
|
CD2
|
A:LEU78
|
5.0
|
36.2
|
1.0
|
CE2
|
A:PHE87
|
5.0
|
32.3
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 4jrg
Go back to
Chlorine Binding Sites List in 4jrg
Chlorine binding site 3 out
of 4 in the The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl201
b:31.0
occ:1.00
|
CL2
|
B:I09201
|
0.0
|
31.0
|
1.0
|
C23
|
B:I09201
|
1.7
|
33.1
|
1.0
|
C22
|
B:I09201
|
2.7
|
30.2
|
1.0
|
C24
|
B:I09201
|
2.7
|
31.1
|
1.0
|
CG
|
B:HIS92
|
3.6
|
30.2
|
1.0
|
CD2
|
B:LEU50
|
3.7
|
27.4
|
1.0
|
CA
|
B:HIS92
|
3.7
|
30.3
|
1.0
|
CB
|
B:HIS92
|
3.7
|
30.1
|
1.0
|
CE2
|
B:TYR96
|
3.8
|
28.8
|
1.0
|
CD2
|
B:TYR96
|
3.8
|
28.9
|
1.0
|
O
|
B:HIS92
|
3.8
|
28.9
|
1.0
|
CD2
|
B:HIS92
|
3.8
|
29.8
|
1.0
|
CG2
|
B:ILE95
|
3.8
|
27.1
|
1.0
|
CB
|
B:ILE95
|
3.9
|
27.6
|
1.0
|
ND1
|
B:HIS92
|
4.0
|
29.7
|
1.0
|
C21
|
B:I09201
|
4.0
|
32.4
|
1.0
|
C25
|
B:I09201
|
4.0
|
31.9
|
1.0
|
CD1
|
B:LEU50
|
4.1
|
31.4
|
1.0
|
CD1
|
B:ILE95
|
4.1
|
27.9
|
1.0
|
C
|
B:HIS92
|
4.2
|
29.7
|
1.0
|
NE2
|
B:HIS92
|
4.3
|
30.9
|
1.0
|
CE1
|
B:HIS92
|
4.4
|
29.7
|
1.0
|
CG
|
B:LEU50
|
4.5
|
30.3
|
1.0
|
C26
|
B:I09201
|
4.5
|
31.2
|
1.0
|
CG1
|
B:ILE95
|
4.6
|
31.0
|
1.0
|
N
|
B:TYR96
|
4.8
|
29.7
|
1.0
|
N
|
B:HIS92
|
4.9
|
29.1
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 4jrg
Go back to
Chlorine Binding Sites List in 4jrg
Chlorine binding site 4 out
of 4 in the The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of The 1.9A Crystal Structure of Humanized Xenopus MDM2 with RO5313109 - A Pyrrolidine MDM2 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl201
b:42.4
occ:1.00
|
CL3
|
B:I09201
|
0.0
|
42.4
|
1.0
|
C34
|
B:I09201
|
1.7
|
37.5
|
1.0
|
C35
|
B:I09201
|
2.7
|
36.5
|
1.0
|
C33
|
B:I09201
|
2.7
|
36.7
|
1.0
|
CD1
|
B:ILE57
|
3.7
|
29.7
|
1.0
|
CE2
|
B:PHE82
|
3.9
|
33.6
|
1.0
|
CB
|
B:LEU53
|
3.9
|
28.4
|
1.0
|
CD1
|
B:LEU53
|
4.0
|
28.2
|
1.0
|
C36
|
B:I09201
|
4.0
|
36.8
|
1.0
|
C32
|
B:I09201
|
4.0
|
36.4
|
1.0
|
CZ
|
B:PHE82
|
4.0
|
32.8
|
1.0
|
CZ
|
B:PHE87
|
4.1
|
30.7
|
1.0
|
CG2
|
B:ILE95
|
4.1
|
27.1
|
1.0
|
CE1
|
B:PHE87
|
4.3
|
32.7
|
1.0
|
C31
|
B:I09201
|
4.5
|
35.5
|
1.0
|
CG
|
B:LEU53
|
4.6
|
30.3
|
1.0
|
CD2
|
B:LEU78
|
4.9
|
36.0
|
1.0
|
C
|
B:LEU53
|
4.9
|
28.7
|
1.0
|
CG1
|
B:ILE57
|
4.9
|
30.3
|
1.0
|
O
|
B:LEU53
|
5.0
|
27.9
|
1.0
|
|
Reference:
Q.Ding,
Z.Zhang,
J.J.Liu,
N.Jiang,
J.Zhang,
T.M.Ross,
X.J.Chu,
D.Bartkovitz,
F.Podlaski,
C.Janson,
C.Tovar,
Z.M.Filipovic,
B.Higgins,
K.Glenn,
K.Packman,
L.T.Vassilev,
B.Graves.
Discovery of RG7388, A Potent and Selective P53-MDM2 Inhibitor in Clinical Development. J.Med.Chem. V. 56 5979 2013.
ISSN: ISSN 0022-2623
PubMed: 23808545
DOI: 10.1021/JM400487C
Page generated: Sun Jul 21 17:39:36 2024
|